Literature DB >> 9489871

Surgical removal of atrial septal defect occlusion system-devices.

J Bohm1, K Bittigau, F Köhler, G Baumann, W Konertz.   

Abstract

OBJECTIVE: Since 1976 a number of similar transvenous atrial septal defect occlusion systems have been developed and applied to prevent surgical intervention with extracorporeal circulation and the complications involved. One of them is the so called atrial septal defect occlusion system (ASDOS-device; Dr Ing Osypka, Germany). METHOD AND
RESULTS: In our institution, eight ASDOS-devices were implanted in adults during the last year. In six individual cases, these devices were explanted because of thrombosis, residual shunts, deformations of the umbrella, disconnection of the system and atrial perforation with hemopericard. This occured 17-380 days after the implant. The surgical removal was uncomplicated in all cases.
CONCLUSIONS: Because the complication rate of the ASDOS-device was unacceptably high, surgical repair was preferred.

Entities:  

Mesh:

Year:  1997        PMID: 9489871     DOI: 10.1016/s1010-7940(97)00270-4

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  4 in total

1.  Total endoscopic robotic atrial septal defect repair in a patient with dextrocardia and situs inversus totalis.

Authors:  Kenji Iino; Go Watanabe; Norihiko Ishikawa; Shigeyuki Tomita
Journal:  Interact Cardiovasc Thorac Surg       Date:  2011-12-26

Review 2.  Atrial septum defect closure device in a beating heart, from the perspective of a researcher in artificial organs.

Authors:  Yasuko Tomizawa
Journal:  J Artif Organs       Date:  2012-06-23       Impact factor: 1.731

3.  The gold standard for atrial septal defect closure: current surgical results, with an emphasis on morbidity.

Authors:  R J F Baskett; E Tancock; D B Ross
Journal:  Pediatr Cardiol       Date:  2003 Sep-Oct       Impact factor: 1.655

4.  Totally endoscopic closure of an atrial septal defect using the da Vinci Surgical System: report of four cases.

Authors:  Yujiro Kikuchi; Teruaki Ushijima; Go Watanabe; Norihiko Ishikawa; Munehisa Takata; Yoshitaka Yamamoto
Journal:  Surg Today       Date:  2010-01-28       Impact factor: 2.549

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.